Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Passage BIO, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 87
- −19 vs. Q1 2022
- Shares held
- 42.2M
- −608.2K (−1.4%) vs. Q1 2022
- Total value
- $99.6M
- −$33.1M (−24.9%) vs. Q1 2022
- New holders
- 15
- 20 more added
- Sold out
- 34
- 36 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −23,317−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −18,414−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −17,886−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −14,517−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −13,750−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −13,270−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −12,705−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,554−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −10,752−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −4,485−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,908−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −2,262−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,950−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,377−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −712−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −290−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Laurel Wealth Advisors LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |